Journal of Pain Research

NeurAxis Announces Results of Comparative Study of IB-Stim™ and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders

Retrieved on: 
Tuesday, September 26, 2023
International Classification of Functioning, Disability and Health, Neuraxis, Comparison, Cyproheptadine, FAPD, API, Clinical trial, Amitriptyline, Abdominal pain, FDI, Disability, Patient, Journal of Pain Research, Children's Hospital & Medical Center, Adolescence, Cincinnati, NSS, NYSE, Medical imaging

Led by the Cincinnati Children’s Hospital Medical Center, the comparative study concluded that IB-Stim™ may be a good non-pharmacologic alternative for FAPD.

Key Points: 
  • Led by the Cincinnati Children’s Hospital Medical Center, the comparative study concluded that IB-Stim™ may be a good non-pharmacologic alternative for FAPD.
  • The publication , Percutaneous electrical nerve field stimulation compared to standard medical therapy in adolescents with functional abdominal pain disorders, featured in the September 19th 2023 Frontiers in Pain Research, reviewed records of 101 adolescents treated with 4 weeks of IB-Stim™, amitriptyline or cyproheptadine.
  • In the study, 59% of patients in the IB-Stim group had failed prior standard medical therapy.
  • Dr. Adrian Miranda, Chief Medical Officer of NeurAxis, said, “It is exciting to see a comparative evaluation of IB-Stim™ with standard medical therapy.

Culver City Shakti Therapy & Healing Services Announces Ketamine Therapy for TRD

Retrieved on: 
Wednesday, September 13, 2023
Narrative, McGarr, Depression, Post, Anxiety, Ketamine-assisted psychotherapy, Post-traumatic stress disorder, PTSD, KAP, Psychotherapy, Research, Pain, Dizziness, Patient, Systematic, Derealization, Journal of Pain Research, Shakti, Ketamine, TDR, Literature, Somnolence, Mental health, Consciousness, Nursing, Pharmaceutical industry

Following the announcement, individuals suffering from mental health conditions who do not respond to traditional treatments can now access Ketamine Assisted Psychotherapy (KAP), launched by the Shakti Therapy & Healing Services clinic in Los Angeles.

Key Points: 
  • Following the announcement, individuals suffering from mental health conditions who do not respond to traditional treatments can now access Ketamine Assisted Psychotherapy (KAP), launched by the Shakti Therapy & Healing Services clinic in Los Angeles.
  • More information about Shakti Therapy & Healing Services, Ketamine Assisted Psychotherapy, and how this treatment helps with treatment-resistant depression can be found at https://www.shaktitherapyhealing.com/post/finding-hope-how-ketamine-ther... .
  • To view an enhanced version of this graphic, please visit:
    Shakti Therapy & Healing Services' recently added treatment option uses a unique approach, combining pre-treatment preparation, ketamine treatment, and integrated therapy, into each visit.
  • An anxiety treatment case study from Shakti Therapy & Healing Services can be read here: https://ketaminesuccessstories.com/best-ketamine-assisted-therapy-anxiet... .

NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS

Retrieved on: 
Tuesday, September 12, 2023
Neuraxis, International Classification of Functioning, Disability and Health, Frontiers, Disability, Parent, Anxiety, Orange County, Policy, Quality of life, Somatization, Abdominal pain, Pain, Publication, Patient, Journal of Pain Research, Guideline, Child, Adolescence, Nausea, Ageing, NYSE, Armour-piercing fin-stabilized discarding sabot, Pharmaceutical industry

The publication , led by investigators from Children’s Hospital of Orange County, investigated changes in gastrointestinal symptoms and quality of life in 31 adolescent patients aged 11 – 18 years with functional abdominal pain disorders (FAPDs) before and after treatment with IB-Stim.

Key Points: 
  • The publication , led by investigators from Children’s Hospital of Orange County, investigated changes in gastrointestinal symptoms and quality of life in 31 adolescent patients aged 11 – 18 years with functional abdominal pain disorders (FAPDs) before and after treatment with IB-Stim.
  • The patients were treated for 4 weeks and data were collected prospectively from both the patient and the parents using validated questionnaires.
  • The global health scores also significantly improved based on both patient and parent reports (p
  • Dr. Adrian Miranda, Chief Medical Officer of NeurAxis said, “We are pleased that outcomes post IB-Stim treatment continue to be replicated at centers of excellence across the country.

Study Finds Hinge Health Reduces Opioid Prescription Initiation by 42%

Retrieved on: 
Thursday, August 31, 2023
Health, Telemedicine, Virtual Medicine, Hospitals, Practice Management, Physical Therapy, Other Health, General Health, Workplace, Pain, Joint, Therapy, Human, Prescription, Journal, Chronic pain, Shoulder, Patient, Hip, Pharmacy, Neck, Journal of Pain Research

The study, published in The Journal of Pain Research, shows that people in Hinge Health’s digital exercise therapy program were 42% less likely to start opioids than those who tried traditional physical therapy (PT).

Key Points: 
  • The study, published in The Journal of Pain Research, shows that people in Hinge Health’s digital exercise therapy program were 42% less likely to start opioids than those who tried traditional physical therapy (PT).
  • In addition, the study found that people who used Hinge Health had 25% fewer opioid prescriptions overall than traditional PT patients after 12 months.
  • “Our digital exercise therapy program helps people manage their pain while avoiding long-term opioid use,” said Dr. Jeff Krauss, Chief Medical Officer, Hinge Health.
  • Participants started the digital back, neck, shoulder, hip or knee program from Hinge Health between January 2020 and October 2020.

Spinal Simplicity Announces New Real-World Fusion Study for It's Minuteman Device

Retrieved on: 
Wednesday, August 30, 2023
Smoker, Simplicity, CT, Engineering, DBM, Cancer, Journal of Pain Research, Radiology, Minutemen, Journal, Lumbar, Fracture, Society, Treatment, PARK, Regulation, Pharmaceutical industry, Medical imaging, Patient

OVERLAND PARK, Kan., Aug. 30, 2023 /PRNewswire-PRWeb/ -- The Journal of Pain Research, the official journal of the American Society of Pain & Neuroscience, published the study, "Instrumented Posterior Arthrodesis of the Lumbar Spine: Prospective Study Evaluating Fusion Outcomes in Patients Receiving an Interspinous Fixation Device for the Treatment of Degenerative Spine Diseases". This studyprospectively evaluates fusion outcomes in patients receiving a Minuteman device for the treatment of degenerative spine diseases.

Key Points: 
  • Spinal Simplicity announces publication of a new, prospective study that demonstrates clinically significant fusion rates in a real-world setting with patients who received the Minuteman device.
  • This study prospectively evaluates fusion outcomes in patients receiving a Minuteman device for the treatment of degenerative spine diseases.
  • "This announcement today reflects what we've known all along: The Minuteman device fuses," said CEO, Todd Moseley.
  • The purpose of this study was to evaluate lumbar spinal fusion outcomes in real-world patients instrumented with the Minuteman device," said Adam Rogers , VP of Regulatory and Engineering.

Independent clinical study shows Curonix’s Freedom® PNS System significantly reduces pain scores and medication usage

Retrieved on: 
Wednesday, June 7, 2023
Freedom, PMID, Peripheral nerve stimulation, Stroke, Quality of life, Interventionism, DSM-IV codes, PNS, Journal, Patient, Risk, NINDS, Peripheral neuropathy, Chronic pain, Journal of Pain Research, SPSS, National Institute of Neurological Disorders and Stroke, Dentistry, Birth control, Pain

The results showed that patients significantly reduced both pain scores and medication usage, highlighting the Freedom PNS System as a successful, long-term, and less invasive treatment option for patients suffering from chronic pain.

Key Points: 
  • The results showed that patients significantly reduced both pain scores and medication usage, highlighting the Freedom PNS System as a successful, long-term, and less invasive treatment option for patients suffering from chronic pain.
  • This independent retrospective study reviewed the electronic medical records of 57 patients over 24 months who were treated for different pain neuralgias with the Freedom PNS technology.
  • This further supports that the Freedom PNS System is an efficient and powerful treatment option for patients seeking long-term relief from their chronic pain.
  • Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states.

New Study: Hinge Health Prevents Chronic Pain After Recent Injury

Retrieved on: 
Tuesday, November 29, 2022
Professional Services, Health, Health Insurance, Human Resources, Physical Therapy, General Health, Mental health, Verizon Communications, University, US Foods, L.L.Bean, Multimedia, Ankle, University of California, Pain, Risk, Physician, Chronic pain, Therapy, Salesforce, University of Rhode Island, MSK, Depression, Journal of Pain Research, Southern Company, Journal, Quality of life, Motion, Poultry

This new prospective study with 171 participants, published in the Journal of Pain Research , also showed Hinge Health participants achieved freedom from chronic pain faster than nonparticipants.

Key Points: 
  • This new prospective study with 171 participants, published in the Journal of Pain Research , also showed Hinge Health participants achieved freedom from chronic pain faster than nonparticipants.
  • Since measuring pain alone gives a limited view of efficacy, this study used a more complete definition of chronic pain prevention, including pain, function, depression, and anxiety scores.
  • (Graphic: Business Wire)
    If left untreated, acute pain, such as a sprained ankle, can progress to chronic or long-term pain.
  • Our study required improvements in pain, function, and mental health to qualify as avoiding chronic pain.

Tonix Pharmaceuticals Announces Data from an in vitro Study of the Impact of Oxytocin on Human Neurons at Neuroscience 2022, the Annual Meeting of the Society for Neuroscience

Retrieved on: 
Wednesday, November 16, 2022
COVID-19, Long COVID, Prader–Willi syndrome, Infection, Psychiatry, Degenerative disease, Science, Magnesium, Journal of Pain Research, RPV, Food, IND, Pain, Poster, Smallpox, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Monkeypox, Fibromyalgia, Society, Government, Annual report, Orphan drug, Neuron, Inflammation, Central nervous system, Autoimmunity, Migraine, CNS, Security (finance), Breakthrough therapy, SL, Neurology, Cancer, Stanford University, Risk, Research, Therapy, Failure, Investigational New Drug, CD40L, Disease, Hydrogen chloride, Analgesic, FDA, MDD, Pharmaceutical industry, Neuroscience, Oxytocin, CD154, Tonix Pharmaceuticals

This study of the effects of oxytocin on isolated human sensory neurons adds to the growing evidence that oxytocin plays a key role in pain modulation.

Key Points: 
  • This study of the effects of oxytocin on isolated human sensory neurons adds to the growing evidence that oxytocin plays a key role in pain modulation.
  • To that end, we look forward to initiating our Phase 2 study of intranasal oxytocin in chronic migraine by the end of 2022.
  • The study also showed that oxytocin inhibits these neurons, suggesting a mechanism by which oxytocin can produce analgesia.
  • The results of this study are consistent with data from animal models and provide support for the use of oxytocin agonists for the treatment of pain.

Relievant Medsystems Announces Publication of ASPN Guidelines on the Diagnosis and Treatment of Vertebrogenic Low Back Pain with Basivertebral Nerve Ablation

Retrieved on: 
Tuesday, September 20, 2022
Inflammation, Time, Safety, Vertebra, Journal, USPSTF, FDA, Brain, Journal of Pain Research, University of Kansas Health System, Society, Treatment, University, Patient, BVN, Physician, CEO, Technology, Pain, Quality of life, Diagnosis, ASPN, GLOBE, Dentistry, Medical imaging

Following the publication of these guidelines, physicians can confidently recommend BVN ablation as the first treatment for patients presenting with anterior column pain and Modic changes* after failing six months of conservative care.

Key Points: 
  • Following the publication of these guidelines, physicians can confidently recommend BVN ablation as the first treatment for patients presenting with anterior column pain and Modic changes* after failing six months of conservative care.
  • The ASPN best practice guidelines are reflective of a marked shift in how we treat and provide life-changing, long-lasting improvement for patients with chronic vertebrogenic low back pain.
  • Relievant Medsystems minimally invasive Intracept Procedure is the only FDA-cleared treatment for chronic vertebrogenic low back pain.
  • The technology uses targeted radiofrequency energy to stop the basivertebral nerve from transmitting pain signals to the brain.

Sword Health Publishes the first Clinical Study that demonstrates the effectiveness of digital care programs in Acute Low Back pain

Retrieved on: 
Tuesday, August 9, 2022
Depression, Cardinal Health, Exercise, Dell, Travel, Risk, Chronic pain, Trial of the century, Low back pain, Mental health, GLOBE, Population, Cisco Systems, BioMed Central, Disability, Danaher, MSK, Pain, LBP, State Farm, Patient, Education, Program, Absenteeism, Therapy, Pepsi, Back pain, Anxiety, Journal of Pain Research, Gold, Journal, Digital, Self-management, Time, Adult, Medicine

The study, published in the Journal of Pain Research , focused on clinical outcomes in members going through Swords care programs for acute low back pain.

Key Points: 
  • The study, published in the Journal of Pain Research , focused on clinical outcomes in members going through Swords care programs for acute low back pain.
  • Low back pain (LBP) has a very high lifetime prevalence (70-80%) and is a leading cause of absenteeism and costs.
  • With this study, Sword further reinforces the evidence around its digital programs for acute MSK conditions.
  • Sword Health is the worlds fastest growing digital musculoskeletal (MSK) care provider, on a mission to free two billion people from pain.